CoreView Advisors was built on a simple premise: growth-stage companies deserve finance leadership that's been in the seat — not on the sidelines.
CoreView Advisors partners with venture-backed biotech and life sciences companies that need experienced leadership across finance, accounting, and back-office operations.
We embed alongside your team to build the infrastructure that lets you scale with confidence — from first institutional round through commercial launch.
Too many growth-stage companies are forced to choose between hiring a full-time CFO they can't yet afford and outsourcing to firms that don't understand biotech. CoreView exists to close that gap — senior-caliber finance and operations leadership, right-sized for your stage.
We work exclusively with venture-backed life sciences companies navigating the complexity of clinical-stage operations, capital raises, and board-level governance.
Companies advancing through IND-enabling studies and Phase I–III trials, managing complex R&D budgets across multiple programs.
Series A through C fundraising, venture debt structuring, and building investor-ready financial models and board materials.
Companies approaching regulatory approval and commercial launch, building the finance and operations infrastructure to scale.
We don't operate from the sidelines. We join your leadership team's workflow — weekly standups, Slack channels, board prep meetings. We're in the room when it matters.
A Series A company doesn't need the same finance infrastructure as a pre-commercial company. We right-size the engagement to where you are — and help you build toward where you're going.
Our team has managed audits, presented to boards, and closed raises at clinical-stage companies. The advice we give is grounded in having done the work — not having read about it.
We actively adopt AI tools in our own workflows and bring that experience to our clients. Finance teams that embrace AI early will compound their advantage.
Faisal brings over 20 years of finance and operations leadership across the biotech and life sciences sector. Prior to founding CoreView, he held senior finance roles at clinical-stage companies, leading finance functions through capital raises, audits, and commercial milestones. He also sits on the board of the Association of Bioscience Financial Officers (ABFO).
His experience spans the full lifecycle of venture-backed companies — from Series A fundraising through commercial launch — with deep expertise in board-level FP&A, capital raises, venture debt structuring, and M&A advisory.
Full-cycle financial management at pivotal clinical-stage companies — audits, board reporting, investor relations, and capital strategy.
Hands-on experience structuring Series A–C raises, evaluating venture debt facilities, and building investor-ready financial models.
Multi-entity accounting and finance management across institutional VC portfolios, building scalable processes across diverse company stages.
Going concern assessments (ASC 205-40), audit preparation, SOX readiness, equity accounting (ASC 718), and financial statement preparation.
Early adoption and implementation of AI tools across finance workflows — from automated reporting to intelligent document processing.
Whether you need a fractional CFO, help structuring a raise, or an AI assessment for your finance team — start with a conversation.
Schedule a Conversation